Emerging Role of Immune Checkpoint Blockade in Pancreatic Cancer

Immune checkpoint blockade (ICB) with programmed cell death protein-1(PD-1)/programmed death ligand -1(PD-L1) antibodies has revolutionized the management of several cancers, especially non-small cell lung cancer, melanoma, urothelial, and renal cancer. Pancreatic ductal adenocarcinoma (PDAC) is one...

Descripción completa

Detalles Bibliográficos
Autores principales: Macherla, Shravanti, Laks, Shachar, Naqash, Abdul Rafeh, Bulumulle, Anushi, Zervos, Emmanuel, Muzaffar, Mahvish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274962/
https://www.ncbi.nlm.nih.gov/pubmed/30405053
http://dx.doi.org/10.3390/ijms19113505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274962/
https://www.ncbi.nlm.nih.gov/pubmed/30405053
http://dx.doi.org/10.3390/ijms19113505

Ejemplares similares